NOVAVAX INC — Director's Dealing 2016

Mar 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-03-15

Reporting Person: Herrmann John A III (SVP, General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-15	Stock Option (Right to buy)	$4.99	A	225000	Acquired	2026-03-15	Common Stock (225000)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. 2015 Stock Incentive Plan vest on the first anniversary of the March 15, 2016 grant date, and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years subject to continued employment through the vesting date.